Teleflex (TFX) is in discussions to acquire Biotronik SE & Co.’s vascular intervention unit, offering to buy the German medical technology firm’s business for EUR 500M to EUR 1B, people familiar with the matter told Bloomberg’s Sonja Wind, Arno Schuetze, and Eyk Henning. A deal could be reached as soon as this month, one of the sources is reported to have said.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TFX:
- Teleflex price target lowered to $227 from $255 at Truist
- Teleflex price target lowered to $245 from $266 at Raymond James
- Teleflex price target lowered to $250 from $275 at Mizuho
- Teleflex price target lowered to $245 from $275 at RBC Capital
- Teleflex Announces Q3 2024 Financial Results
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
